Tilray Brands, Inc. (TLRY) earnings date
Jan 8, 2027, before open estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q2 FY2027
- Confidence
- 40% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-18
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 39 days, typically, give or take 10 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q1 FY2027 | Thu, Oct 8, 2026 | before open | 38 | 8-K |
| Q4 FY2026 | Tue, Jul 28, 2026 | after close | 58 | 8-K |
| Q3 FY2026 | Wed, Apr 1, 2026 | before open | 32 | 8-K |
| Q2 FY2026 | Thu, Jan 8, 2026 | after close | 39 | 8-K |
| Q1 FY2026 | Thu, Oct 9, 2025 | before open | 39 | 8-K |
| Q4 FY2025 | Mon, Jul 28, 2025 | after close | 58 | 8-K |
| Q3 FY2025 | Tue, Apr 8, 2025 | before open | 39 | 8-K |
| Q2 FY2025 | Fri, Jan 10, 2025 | before open | 41 | 8-K |
What they guided beta
| Q1 FY2027 | "EX-99.1 2 exh_991.htm PRESS RELEASE EdgarFiling EXHIBIT 99.1 Tilray Brands Delivers Record Q1 Fiscal 2027 Revenue and Record Q1 Gross Profit, Demonstrating the Power of Its Global Platform, Driven by Double-Digit Year-Over-Year Growth Across International Cannabis, Beverage and Pharmaceutical Distribution First-Quarter Results Reinforce Tilray’s Progress Converting Global Scale, Disciplined Execution and Category Leadership into Higher Revenue, Expanded Gross Profit and Continued Momentum Record First-Quarter Net Revenue of $257 Million, Up 23% Year-Over-Year, with Gross Margin Expanding by" exhibit |
| Q1 FY2027 | "Fiscal Year 2027 Guidance For its fiscal year ending May 31, 2027, the Company reaffirms its expectation to achieve adjusted EBITDA 3 of $68 million to $75 million, representing double-digit growth as compared to fiscal year 2026." exhibit |
| Q1 FY2027 | "Management’s guidance for adjusted EBITDA 3 is provided on a non-GAAP basis and excludes stock-based compensation; change in fair value of contingent consideration; purchase price accounting step-up; impairments of intangible assets and goodwill; other than temporary change in fair value of convertible notes receivable; litigation costs; integration and restructuring costs; transaction-related costs; and other non-operating income (expenses) and non-recurring items that may be incurred during the Company’s fiscal year 2027, which the Company will continue to identify as it reports its future f" exhibit |
| Q1 FY2027 | "The Company cannot reconcile its expected adjusted EBITDA 3 to net income under “Fiscal Year 2027 Guidance” without unreasonable effort because certain items that impact net income and other reconciling metrics are out of the Company’s control and/or cannot be reasonably predicted at this time. ____________________________________________________________________________________________________ (1) Net (debt) cash is a non-GAAP financial measure." exhibit |
| Q4 FY2026 | "EX-99.1 2 exh_991.htm PRESS RELEASE EdgarFiling EXHIBIT 99.1 Tilray Brands Delivers Record Fiscal 2026 Revenue and Adjusted EBITDA; Demonstrating the Strength of its Diversified Global Platform Across Cannabis, Beverage, Hospitality and Wellness Record Fiscal Year Net Revenue of $ 915 Million, Record Gross Profit, Consistent Adjusted Gross Margin 3 and Record Adjusted EBITDA 5 Highlights the Strength of Tilray’s Scaled Businesses and Profitable Growth Strategy International Medical Cannabis Revenue Increased 34% for the Fiscal Year, Reinforcing Tilray's Leadership Across Europe and Expandin" exhibit |
| Q4 FY2026 | "Simon continued, “As we enter Fiscal 2027, we expect over $1 billion in annual revenue, with a stronger company than ever before." exhibit |
| Q4 FY2026 | "Fiscal Year 2027 Guidance For its fiscal year ending May 31, 2027, the Company expects to achieve adjusted EBITDA 5 of $68 million to $75 million, representing double digit growth as compared to fiscal year 2026." exhibit |
| Q4 FY2026 | "Management’s guidance for adjusted EBITDA 5 is provided on a non-GAAP basis and excludes stock-based compensation; change in fair value of contingent consideration; purchase price accounting step-up; impairments of intangible assets and goodwill; other than temporary change in fair value of convertible notes receivable; litigation costs; integration and restructuring costs; transaction-related costs; and other non-operating income (expenses) and non-recurring items that may be incurred during the Company’s fiscal year 2027, which the Company will continue to identify as it reports its future f" exhibit |
| Q4 FY2026 | "The Company cannot reconcile its expected adjusted EBITDA 5 to net income under “Fiscal Year 2027 Guidance” without unreasonable effort because certain items that impact net income and other reconciling metrics are out of the Company’s control and/or cannot be reasonably predicted at this time. ______________________________ (1) Cash, restricted cash and Marketable Securities is a non-GAAP financial measure." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/TLRY
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/TLRY
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/TLRY/"><img src="https://veritasdata.dev/embed/TLRY.svg" alt="TLRY earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/TLRY/)
Script
<script async src="https://veritasdata.dev/embed/TLRY.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/TLRY"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.